Physician profile
Kotomi Obayashi
NPI 1609491513
$7,278.42
in general payments reported to CMS, 2019-2025
16 companies · $5,892 in 2025
The $5,892 reported for 2025 was more than what 97% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.96 · 2022: $34.62 · 2023: $90.03 · 2024: $1,247 · 2025: $5,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,461 · Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,460.85 |
| Food and Beverage | $2,767.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,752.03 | 2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Spinal Simplicity, LLC | $1,067.77 | 2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $893.06 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $758.86 | 2024-2025 | Proclaim, Eterna |
| Curonix LLC | $641.25 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $405.20 | 2023-2025 | Sprint Pns System |
| Stryker Corporation | $303.70 | 2025 | Spinejack, Optablate, Mild Device Kit |
| Nevro Corp. | $119.50 | 2024 | Senza |
| Si-Bone, INC. | $84.55 | 2025 | |
| Abbvie INC. | $77.11 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $59.65 | 2022-2023 | Dysport |
| Pfizer INC. | $32.01 | 2025 | |
| Globus Medical, INC. | $31.65 | 2025 | Senza |
| Astrazeneca Pharmaceuticals LP | $18.75 | 2025 | Farxiga |
| Novo Nordisk INC | $18.37 | 2025 | Ozempic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kotomi Obayashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.